Organization
Joslin Diabetes Center
3 clinical trials
1 abstract
Clinical trial
A Pilot Trial of Adding Oral Hypoglycemic Therapy to Insulin Treatment in Monogenic Variant Carriers of the Joslin 50-Year Medalist StudyStatus: , Estimated PCD: 2024-12-01
Clinical trial
Mechanisms of Hypoglycemia in Patients Without DiabetesStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass SurgeryStatus: Completed, Estimated PCD: 2016-07-01
Abstract
Obesity, dyslipidemia, and diabetes as determinants of response to immune checkpoint inhibitors in non-small cell lung cancer.Org: Beth Israel Deaconess Medical Center, Roswell Park Comprehensive Cancer Center, Mount Auburn Hospital, Harvard Medical School, Lahey Hospital and Medical Center, Burlington, MA,